Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence.

Llach CD, Badulescu S, Tabassum A, Shah H, Gill H, Le GH, Vieta E, McIntyre RS, Rosenblat JD, Mansur RB

Open source

DOI
10.1038/s41380-025-03261-0
Published
2026 Jan
Container
Molecular psychiatry
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41380-025-03261-0,
  title = {Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence.},
  author = {Llach CD and Badulescu S and Tabassum A and Shah H and Gill H and Le GH and Vieta E and McIntyre RS and Rosenblat JD and Mansur RB},
  year = {2026},
  journal = {Molecular psychiatry},
  doi = {10.1038/s41380-025-03261-0},
  url = {https://doi.org/10.1038/s41380-025-03261-0}
}

RIS

TY  - JOUR
TI  - Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence.
AU  - Llach CD
AU  - Badulescu S
AU  - Tabassum A
AU  - Shah H
AU  - Gill H
AU  - Le GH
AU  - Vieta E
AU  - McIntyre RS
AU  - Rosenblat JD
AU  - Mansur RB
PY  - 2026
JO  - Molecular psychiatry
DO  - 10.1038/s41380-025-03261-0
UR  - https://doi.org/10.1038/s41380-025-03261-0
ER  - 

APA

CD, L., S, B., A, T., H, S., H, G., GH, L., E, V., RS, M., JD, R., & RB, M. (2026). Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence.. Molecular psychiatry. https://doi.org/10.1038/s41380-025-03261-0

Source records